SAN DIEGO, CA - Hypnoz Therapeutic Devices announces that the United States Patent and Trademark Office has issued US Patent No. 8,001,970 for the JED™. The entire JED™ system is now protected by issued patents in the United States.

SAN DIEGO, CA - Hypnoz Therapeutic Devices announces that the United States Patent and Trademark Office has issued US Patent No. D634,015 S and D631,969 S for the JED™ disposable cup design.

SAN DIEGO, CA - Hypnoz Therapeutic Devices announces that the Jaw Elevation Device (JED™) is now shipping in the US through its exclusive USA distributor, LMA of North America. JED™ will debut at the annual Society for Airway Management meeting in Chicago, September 24-26th, 2010 and at the American Society of Anesthesiologists meeting in San Diego, October 16-20th, 2010.

SAN DIEGO, CA October 17, 2010 - Hypnoz Therapeutic Devices, Inc., developer of the Jaw Elevation Device (JED), has announced that the JED will be exhibited at, booth #1327 LMA of North America, at the American Society of Anesthesiologists Annual Meeting in San Diego October 17th-21st, 2010. The Jaw Elevation device is designed to assist providers in maintaining an open airway hands-free.

“We are pleased to launch the JED with our distributor LMA of North America in San Diego, location of both our company headquarters.  This is the debut of our flagship product and we are encouraged by the enthusiasm for the device by the medical community” said April C. King, M.S.N., CRNA, President and CEO of Hypnoz Therapeutics, Inc.

The ASA Annual Meeting is the largest gathering of anesthesiologists and anesthesia care vendors in the world, and is the major venue for introduction of new products to the anesthesia community.  15,000 attendees are expected to be in attendance for the conference.

SAN DIEGO, CA August 7, 2010 - Hypnoz Therapeutic Devices, Inc. has announced the JED will be exhibited at their exclusive distributors booth, LMA of North America, at the Association of Nurse Anesthetists in Seattle, Washington on August 7-11th, 2010. The JED™ is an externally applied, non-invasive device, which assists the provider in maintaining an open airway in patients who are sedated or anesthetized.

“This is the first time the JED will be exhibited by our national distributor LMA of North America.  We are excited to have entered into a strategic partnership with one of the most recognized names in anesthesia.” said April C. King, M.S.N., CRNA, President and CEO of Hypnoz Therapeutics, Inc.

The AANA Meeting is held to enhance the practitioners patient care expertise and to keep their practices up to date.  Over 3000 CRNAs and students are expected to attend the conference.

SAN DIEGO, CA - Hypnoz Therapeutic Devices Announces LMA of North America as Exclusive United States Distributor of the Jaw Elevation Device (JED™). Addresses major segment of anesthesia market

SAN DIEGO, CA March 9, 2010 - Hypnoz Therapeutic Devices, Inc. announced today it has signed an Exclusive Distribution Agreement with LMA North America, Inc. The agreement appoints LMANA as the exclusive distributor in the United States of Hypnoz’s first product – the Jaw Elevation Device (JED™).  This agreement represents the parties’ first partnership together.

The JED™ is an externally applied, non-invasive device which assists the provider in maintaining an open airway in patients who are sedated or anesthetized and whose breathing may therefore be compromised.  Convenient and easy-to-apply, the JED™ lifts the patient’s head to flex the neck and elevates the mandible while rotating the head backwards, creating the classic sniffing position. The JED™ will be used in Monitored Anesthesia Care cases or in other situations where the airway may be compromised.  At present, clinicians manage the airway in these cases manually by holding the patients' jaws. The JED™ assists the clinician in keeping the airway open hands free. It is applicable in operating rooms, office practices, oral surgery/dental offices, interventional radiology suites, MRIs or ambulances.

“LMA is the world leader in the marketing and development of the LMA™ laryngeal mask airway,” said April King, CEO of Hypnoz.  “They represent an excellent partner for the distribution of the JED™ as a non-invasive airway support solution.”

“The JED™ complements our airway management portfolio and strategically leverages our experienced sales force by offering yet another innovative airway management tool to share with our customers,” said Steven R. Block, President and CEO of LMA North America.

“Approximately one-third of the 38 million surgical procedures in the United States require an anesthesia care provider to provide sedation while manually supporting the airway. Hypnoz believes that the JED™ will be used as the "hands-free" solution in all of these cases and will become the standard of care for airway protection when sedation or anesthesia is required but the procedure does not necessitate an endotracheal tube or layrngeal mask airway,” said William J. Mazzei, M.D., CMO of Hypnoz.

SAN DIEGO, CA - Hypnoz Therapeutics, Inc., developer of the Jaw Elevation Device (JED), has announced that they will be exhibiting at the American Society of Anesthesiologists Annual Meeting in New Orleans on October 17th-21st. The Jaw Elevation device is designed to assist providers in maintaining an open airway hands free.

“We’re very pleased with the clinical trials we have completed this year and we look forward to exhibiting at the ASA, a premier meeting for educating the medical community,” said April C. King, M.S.N., CRNA, President and CEO of Hypnoz Therapeutics, Inc.

Hypnoz Therapeutics will be showcasing the Jaw Elevation Device at Booth #1359. Visitors to the booth will be able to see how the device places the head in the classic sniffing position to fully open the airway and will be able to try the JED on a live model. Hypnoz Therapeutics personnel will also be meeting with interested parties regarding additional clinical trials and distribution opportunities for the JED.

The annual ASA Meeting is expected to have an attendance of 17,000 and is held to provide current information on new products, services, and technologies useful in the practice of anesthesia.

SAN DIEGO, CA - Hypnoz Therapeutics, Inc., developer of the Jaw Elevation Device (JED), has announced that they will be exhibiting at the Association of Nurse Anesthetists in San Diego on August 8-12.  The Jaw Elevation device is designed to assist providers in maintaining an open airway hands free.

“We’re very pleased with the improvements we’ve made to the JED over the past several months, and we’re excited about the reception it has been getting from the medical community,” said April C. King, M.S.N., CRNA, President and CEO of Hypnoz Therapeutics, Inc.

Hypnoz Therapeutics will be showcasing the Jaw Elevation Device in Booth #752. Visitors to the booth will be able to see how the device places the head in the classic sniffing position to fully open the airway and will be able to try the JED on a live model. Hypnoz Therapeutics personnel will also be meeting with interested parties regarding additional clinical trials and distribution opportunities for the JED.

The annual AANA Meeting is held to update and expand the practitioners’ knowledge in the medical, nursing, and socio-psychological sciences related to nurse anesthesia. 2,200 CRNAs and students are expected to attend the conference.

ORLANDO, FL and SAN DIEGO, CA - Hypnoz Therapeutics, Inc., a venture-stage company developing the Jaw Elevation Device (JED), today announced the first public presentation of its flagship product.  The Company will display the JED to the public at the American Society of Anesthesiologists' Annual Meeting in Orlando, Oct. 18-22, 2008.  The ASA Annual Meeting is the largest gathering of anesthesiologists and anesthesia care vendors in the world, and is the major venue for introduction of new products to the anesthesia community.  Hypnoz will be located at booth #1752 at the Orlando Convention Center.  The JED will be demonstrated to show how it places the head in the classic sniffing position to fully open the airway.  Visitors to the booth will be able to try the JED on a live model. They will seek sites for further clinical studies of the JED and also discuss distribution opportunities with interested vendors.

"We at Hypnoz are very excited to demonstrate our flagship product - JED - at one of the largest worldwide meetings of anesthesia professionals.  We believe that JED will revolutionize patient care and safety during sedation or general anesthesia." said April C. King, M.S.N., CRNA, President and CEO of Hypnoz Therapeutics, Inc.